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Abstract
Background: The aim of the current study is to report our experience with fast-track treatment of patients
undergoing transapical transcatheter aortic valve implantation (TA-TAVI) and to determine perioperative predictors
for fast-track protocol failure.
Methods: Being one of the pioneering centers to start performing TA-TAVI back in 2005, we routinely included
patients undergoing this procedure into our fast-track management program since 2008. Between January 2008
and June 2013, 207 consecutive high-risk patients (mean age 79 ± 7 years, mean Log. EuroSCORE 24 ± 10) who
underwent TA-TAVI accordingly to our institutional fast-track approach were prospectively collected and analyzed.
Uni- and multivariate analysis were performed to identify independent pre- and perioperative predictors of
fast-track protocol failure, defined as inability to discharge the patient from the intensive care unit (ICU) on the day
of surgery or as readmission to the ICU 48 h after the initial discharge.
Results: Fast-track management was successful in 83 % of the patients. 30-day mortality was 8 %. Fast-track
protocol failure (17 %) was associated with an outcome worsening compared to the remaining patients (mortality:
40 % vs. 2 % and mean hospital stay: 19 ± 12 vs. 10 ± 9 days; P = .002). Independent predictors of fast-track protocol
failure were age ≥85 years (OR 3.1; CI 95 % 1.89–6.21), ejection fraction (EF) ≤30 % (OR 2.6; CI 95 % 1.99–7.52),
moderate to severe preoperative mitral valve regurgitation (OR 2.7; CI 95 % 1.27–6.43) and fluoroscopy time ≥12 min
(OR 2.9; CI 95 % 1.28–7.46).
Conclusions: Fast-track patient management following TA-TAVI is safe and reproducible in the majority of patients.
Besides patient-related preoperative risk factors (age ≥85 years, EF ≤30 % and moderate to severe preoperative mitral
valve regurgitation) a technically challenging intraoperative course as evidenced in a prolonged fluoroscopy time are
independent predictors of fast-track protocol failure which is associated with high loss of patient outcome.
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Background
Early pioneer work in 1980s launched the early extuba-
tion as a safe technique in a small series of patients
undergoing cardiac surgery [1, 2]. Since then, the con-
tinuously expanding impact of health economics on the
patient management and the frequently limited financial
resources have led to an increasing interest in fast-track
treatment protocols following cardiac surgery [3].
Transapical transcatheter-based aortic valve implant-
ation (TA-TAVI) has been identified as a safe and efficient
alternative to classic surgery, especially in patients carry-
ing an unacceptably high perioperative risk [4, 5]. Due to
the minimally invasive nature of this approach that elimi-
nates sternotomy and the need of cardiopulmonary bypass
(CPB), TA-TAVI patients may represent a very attractive
cohort for fast-track treatment concepts.
Despite the continuous improvement of the surgical
and anesthesiological management of patients in cardiac
surgery and the insatiable thirst of medical departments
for optimized use of intensive care capacities, TA-TAVI
patients remain a cohort with high perioperative risk pro-
file and limited biological reserves, who rarely “excuse
mistakes” [6, 7]. Thus, the aim of the current study is to
report our institutional experience following fast-track
treatment of patients undergoing TA-TAVI and to identify
predictors for potential fast-track protocol failure.
Methods
Patient population
TA-TAVI was introduced as a novel technique in our de-
partment in 2005 [8]. Fast-track protocol has been rou-
tinely applied for TA-TAVI patients since 2008. Between
January 2008 and June 2013, 207 consecutive high-risk
patients underwent TA-TAVI followed by the fast-track
postoperative treatment approach. The choice of treat-
ment was made at the discretion of the heart team,
consisting of 2 cardiac surgeons, 2 interventional cardi-
ologists and lately 2 anaesthesiologists. From 2007 on
we assessed all TAVI candidates according to the estab-
lished recommendations and guidelines in order to find
the best possible TAVI approach for each individual
patients. Patient data were collected prospectively during
treatment using standardized forms to record demo-
graphic and clinical characteristics as well as procedural
and follow-up data. The local Ethics Committee at the
Hospital of the Johann Wolfgang Goethe University,
Frankfurt/Main, Germany approved the study protocol
and individual patient consent was waived.
Preoperative anaesthesiologic management
After insertion of a radial artery catheter for invasive
monitoring of arterial pressure, anesthesia was intro-
duced using sufentatil (Janssen, Neuss, Germany), diso-
privan (Fresenius Kabi, Bad Homburg, Germany) as well
as rocuronium (Essex pharma, Munich, Germany), and
was maintained with disoprivan (Fresenius Kabi, Bad
Homburg, Germany) and remifentanil (Braun, Melsungen,
Germany). Oropharyngeal intubation and insertion of a
central venous catheter (in the internal jugular vein) was
performed afterwards. Mechanical ventilation with biphasic
positive airway pressure was established after the intub-
ation adjusted to the gas exchange (Dräger Oxylog 3000,
Dräger Medical Germany GmbH, Lübeck, Germany). Fur-
ther anesthesiologic management included a peripheral
venous and urinary catheter. Despite continuous peripheral
oxygen saturation control, respiration was monitored at
fixed time intervals by blood gas analysis measurements.
TA-TAVI procedure
Our institutional protocol for TA-TAVI has been previ-
ously described in detail [9, 10]. Briefly, all operations
were performed in a specially equipped angiography
suite that fulfils the standards of a hybrid operating
room. Besides standard hemodynamic monitoring, trans-
esophageal echocardiography and CPB were routinely
available. A limited left anterolateral incision (5–7 cm), in
the fifth intercostal space, was used to access the apex of
the heart. A bipolar epicardial pacing wire was placed and
tested. Two U stitches with Teflon felt pledgets using 3–0
Prolene polypropylene (Ethicon, Inc., Somerville, NJ) were
placed in the apex of the left ventricle. They served as
purse string for linear closure of the left ventricle at the
end of the procedure. Following balloon valvuloplasty, all
valve deployments were performed with standard volu-
metric inflation of the balloon. Fluoroscopy and trans-
esophageal echocardiography were used to guide the
catheter across the native valve and direct deployment of
the stent at the level of the annulus. During deployment,
the heart was unloaded with rapid ventricular pacing.
Valve function was immediately assessed by angiographic
and echocardiographic visualization. Intercostal blockade
was performed with ropivacaine (Ratiopharm GmbH,
Ulm, Germany). The pericardium was partially closed over
the apex and a left lateral chest tube inserted. The incision
was closed in a standard fashion.
ICU fast-track protocol
All patients were transferred postoperatively intubated
to the intensive care unit (ICU) where ECG, chest radi-
ography and clinical laboratory test as well as blood gas
analysis were immediately performed. The ICU is a 36-
bed unit run by full-time intensivists and cardiac
surgeons with a 2:1 staff to patient ratio. Standard postop-
erative care consisted of mechanical ventilation, cardioa-
citve drugs if indicated, the use of warm air heaters to
maintain noromothermia and analgesia with a combin-
ation of nonsteroidal anti-inflammatory drugs (paraceta-
mol, Ratiopharm GmbH, Ulm, Germany) and intravenous
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morphine boluses (piritramid, Janssen-Cilag GmbH,
Neuss, Germany) as required. Blood gas analyses were re-
peated half-hourly, the laboratory parameters 4 and 8 h
after ICU admission. Hemodynamic monitoring was per-
formed by continuous ECG recording, invasive blood
pressure, central venous pressure measurement and moni-
toring of peripheral and central venous saturation. Mech-
anical ventilation with biphasic positive airway pressure
was turned after the admission to the ICU as soon as pos-
sible to continuous positive airway ventilation with low
positive end-expiratory pressure. Criteria for weaning
from the ventilator included absence of bleeding signs
(chest tube drainage <100 ml/h, stable haemoglobin
values), stable cardiorespiratory conditions (mean arterial
pressure >60 mmHg, central venous saturation >65 and
Horowitz index >200), and absence of high inotropic sup-
port. If patients fulfilled these criteria, sedation agents
were tapered and continuous positive airway ventilation
gradually decreased to a minimum level (FiO2: 35 %,
PEEP: 5–6 mbar and ASB: 6–7 mbar). Extubation was
performed in the presence of appropriate level of con-
sciousness, adequate airway protection reflexes (cough
and swallow) and in the absence of respiratory or cardiac
distress. Patients were discharged from the ICU to the
cardiothoracic ward at least 4 h after extubation but
no later than 09:00 p.m. on the day of surgery. Dur-
ing this period, any increasing requirements for cardi-
oactive drugs, or significant decrease in oxygen
saturation (<90 % despite oxygen mask), urine output,
or level of consciousness, was considered a contra-
indication for discharge. In the cardiothoracic ward
patients monitor surveillance has been performed for
two days after the procedure via continuous ECG,
peripheral oxygen saturation control and non-invasive
blood pressure measurement in a room that fulfils
the conditions of an intermediate care unit.
Reasons for readmission included (1) pulmonary
(respiratory distress characterized by tachypnea, de-
crease in arterial saturation <90 %, Horowitz index <200,
use of accessory muscles or abdominal paradox, inability
to clear secretion); (2) bleeding or pericardial tamponade
(new onset bleeding of more than 200 ml/h or more
than 800 ml/6 h); (3) severe agitation requiring extended
intravenous sedation; (4) upper or lower gastrointestinal
bleeding requiring intervention or surgery; (5) any new
permanent neurologic deficits (PNDs); (6) hemodynamic
instability (any decrease in blood pressure requiring in-
creasing use of cardioactive drugs).
Data analysis
Data are presented as frequency distributions and per-
centages. All continuous data are expressed as means ±
standard deviation. Categorical data are expressed as
counts and proportions. Comparisons were done with 2-
tailed t test for means of normally distributed continu-
ous variables and the Wilcoxon rank sum test for
skewed data. Fisher exact or χ2 test was used to analyse
differences among categorical data. Univariate and step-
wise multivariate logistic regression analysis of peri-
operative variables for adverse outcome was performed
by calculating the odds ratio (OR) with 95 % confidence
interval. Fourteen variables were analysed as follows: age
older than 80, sex, chronic obstructive lung disease,
chronic pulmonary hypertension, arterial hypertension,
diabetes mellitus, cerebrovascular disease, peripheral
vascular disease, chronic renal insufficiency, smoking
history, ejection fraction <30 %, moderate to severe mi-
tral valve regurgitation, previous cardiac surgery and
prolonged fluoroscopy time. Statistical analysis of data
was conducted with commercially available software
(SPSS 20.0 for Windows, SPSS Inc.).
Results
Baseline data
Data from all included patients were eligible for further
analysis. Mean age was 79 ± 7 years, mean Log.
EuroSCORE accounted for 24 ± 10, and 55 % (n = 113)
of patients were men. Fast-track protocol could be
successfully applied in 172 patients (83 %) (group S). In
the remaining 17 % (n = 35) of TA-TAVI patients fast-
track management failed (group F). Demographic data
of both groups are summarized in Table 1.
Postoperative course
Overall, 30-day mortality was 8 % (n = 17) and the inci-
dence of early PND was 1 % (n = 3). Fast-track manage-
ment failure was associated with a significant dramatic
worsening of patient outcome compared to those with
successful implementation of fast-track management, as
reflected by an increased mortality (group S: 2 % vs.
group F: 40 %, P = .001) and increased postoperative
complication rate such as new renal failure requiring
dialysis (group S: 7 % vs. group F: 26 %, P = .03). A de-
tailed description of the postoperative course of both
groups is presented in Table 2. Figure 1 illustrates the
time to event curves for 30-day survival of both groups
S and F. The in-hospital stay after failed fast-track proto-
col was significantly longer (group S: 10 ± 9 days vs.
group F: 19 ± 12 days, P = .002).
Causes of fast-track failure
Fast-track protocol failed in 35 patients (group F, 17 %).
Twenty-one patients had prolonged ICU-stay and 14 pa-
tients required readmission to the ICU within 48 h after
initial discharge. Four out of 14 patients, died after re-
admission to the ICU. The remaining 10 patients could be
successfully discharged to the general yard and finally
from hospital in the further postoperative course. Reasons
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Table 1 Baseline demographic and clinical characteristics of group S (successful fast-track protocol) and group F (fast track protocol
failure)
Group S (n = 172) Group F (n = 35)
No. % No. %
Variables p
Age (years) 79.2 ± 6.1 86.5 ± 2.6 0.008
Male 88 51 25 71 0.04
STS risk score 8.2 ± 6.8 11.4 ± 8.4 0.18
Log. EuroSCORE 23.2 ± 9.7 25.8 ± 8.3 0.46
Atrial fibrillation 50 29 9 27 0.26
Diabetes 34 20 12 35 0.11
Arterial Hypertension 160 93 29 82 0.21
Pulmonary Hypertension 115 67 26 75 0.25
Previous stroke 26 15 6 17 0.15
Peripheral vascular disease 46 27 14 40 0.08
COPD 53 31 16 47 0.17
Chronic renal failure 91 53 29 82 0.31
Mean ejection fraction (%) 47 ± 15 31 ± 5 0.05
Mean pressure gradient (echo; mmHg) 51 ± 19 44 ± 27 0.14
Aortic valve area (cm) 0.66 ± 0.22 0.72 ± 0.48 0.09
Previous cardiac surgery 50 29 12 35 0.29
Preop. MV regurgitation (moderate to severe) 20 11 12 35 0.05
COPD chronic obstructive pulmonary disease, Chronic renal failure = glomerular filtration rate < 60 ml/min/1.73 m2; EuroSCORE European system for cardiac risk
evaluation, Group F fast track protocol failure, Group S successful fast-track protocol, MV mitral valve, STS risk score The Society of Thoracic Surgeons’ risk sore
Table 2 Detailed postoperative course of group S (successful fast-track protocol) and group F (fast track protocol failure)
Group S (n = 172) Group F (n = 35)
No. % No. %
Variables p
Fluoroscopy time (min) 4.7 ± 2.5 12.9 ± 1.4 0.04
Ventilation time (h) 4.6 ± 1.0 58 ± 15 0.04
Postoperative complications
- PM-Implantation 9 5 0 0 0.001
- Early-PND 2 1 1 3 0.13
- Major bleeding requiring revision 3 2 10 29 0.02
- Gastrointestinal complications requiring endoscopic intervention 1 1 5 14 0.07
- Acute kidney injury requiring dialysis 12 7 9 26 0.03
Early outcome
30-day Mortality 3 2 14 40 0.001
Sepsis/MOV 1 1 10 29
Mesenteric ischemia 1 1 2 6
Arryythmia 0 0 1 3
Unknown 1 1 1 3
Hospital-stay (d) 10 ± 9 19 ± 12 0.002
Group F fast track protocol failure, Group S successful fast-track protocol, MOV Multi organ failure, PM Pacemaker, PND permanent neurologic deficit
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for fast-track failure were as follows: respiratory failure
(49 %, n = 17/35), major bleeding (29 %, n = 10/35), severe
agitation (11 %, n = 4/35), gastrointestinal complications
(9 %, n = 3/35) and PND (3 %, n = 1/35). Figure 2 illus-
trates the causes of fast-track failure.
Predictors for fast-track management failure
Independent predictors of fast-track protocol failure were
age ≥85 years (OR 3.1; CI 95 % 1.89–6.21, P = .004), ejec-
tion fraction (EF) ≤30 % (OR 2.6; CI 95 % 1.99–7.52,
P = .03), moderate to severe preoperative mitral valve
regurgitation (OR 2.7; CI 95 % 1.27–6.43, P = .008)
and fluoroscopy time ≥12 min (OR 2.9; CI 95 %
1.28–7.46, P = .04).
Discussion
Prolonged sedation and ventilatory support have been
practiced as an “undisputed standard” since open-heart
surgery with use of CPB has been established in the
1950s [11, 12]. Monitoring of potential postoperative
complications such as hemorrhage, myocardial ischemia
and systemic inflammatory response syndrome following
CPB was thought to be adequately performed in sedated
patients under stable and easily supervised conditions
[12]. Thus, anesthesiologic management with high dose
opioid anesthetics made extended ventilatory support of
cardiac surgical patients indispensable [13, 14]. However,
cost containment and efficient resource use force the
pendulum back to the debate of early extubation for pa-
tients undergoing cardiac surgery [1–3]. The improve-
ment in anesthesia management coupled with advanced
surgical techniques such as minimally invasive cardiac
surgery procedures have made early extubation feasible
and the concept of balanced anesthesia rather than
high-dose narcotics for cardiac procedures has been
introduced [4, 15–17]. Nowadays, fast track cardiac
anesthesia with early extubation is widely accepted as
important step in the recovery process for adult patients
[3]. Due to the minimally invasive nature of TA-TAVI
that eliminates sternotomy and the need for CPB, TA-
Fig. 1 Time to event curves for 30-day survival. Events were calculated
with the use of Kaplan Meier methods and were compared using Log
rank test. Number of patients at risk is indicated for both groups.
Group S denotes patients with successful fast-track protocol after
TA-TAVI, whereas Group F represents those patients with fast-track
management failure
Fig. 2 Causes of fast-track failure. ICU = intensive care unit; PND = permanent neurologic deficit
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TAVI patients represent a particularly attractive cohort
for fast-track management concepts [18, 19]. Thus, we
sought to investigate the results after routine implemen-
tation in our institute with special focus on the risk fac-
tors that may predict fast-track protocol failure.
Undoubtedly, our TA-TAVI patients present a cohort
with high perioperative risk profile, considering the
mean age of 79 ± 7 years and the mean EuroSCORE of
24 ± 10 but despite their limited biological reserves fast-
track protocol could be successfully applied in 83 %
(Group S) of them. Since, to the best of our knowledge,
no available data are published dealing specifically with
fast-track management in TA-TAVI patients, only a lim-
ited comparison of our results to the literature can be fa-
cilitated. Yet, our fast-track protocol success-rate seems
to be in line with data published from Haanschoten
et al. in 2012, reporting a fast-track protocol success rate
by 5367 low risk cardiac surgical patients of 84 % [20].
The ultra short ICU time of Group S could not be trans-
lated in a very short hospital stay. Considering the lim-
ited biological reserves of this frail patient cohort an
average of 10 days hospital stay for completion of
physiotherapy treatment, enabling patients of Group F
to be discharged either at home or at a rehabilitation
center, is not a unique finding in our series. Our data re-
garding hospital stay are in line with the results reported
from Vancouver following TA-TAVI in 178 patients with
a mean length of hospital stay of 12 days [21].
The ICU readmission rates 48 h after the initial dis-
charge has been also reported to be 2-5 % for low risk
cardiac surgery patients [22–24]. In our series, the re-
admission rate reached 7 %, which may be seen as a sat-
isfactory result, considering the high-risk profile of our
patients. Similar to other reports, the most common rea-
son for ICU-readmission was pulmonary insufficiency
[25–27]. Thus, the possibility of providing respiratory
support via non-invasive ventilation in a general ward
and the active follow-up of TA-TAVI patients after ICU
discharge by a dedicated team of respiratory therapists
has been identified as an important issue in our clinic.
In this context, we believe that avoidance of volume
overload in the early perioperative period as well as
pain-free management and early mobilisation are of ut-
most importance for the optimal pulmonary recovery of
fast-track TA-TAVI patients.
Another important finding of the current study is that
any fast-track management failure is associated with
prolonged hospital stay and dramatic worsening of pa-
tient outcome. Furthermore, failed fast-track manage-
ment led to an increased postoperative complication
rate such as renal failure requiring dialysis. Although
speculative, a possible reason for the high mortality and
morbidity in ICU readmission patients may be the early
transfer of these patients to the ward. Thus it would be
advantageous to identify and focus on subgroups of TA-
TAVI patients at risk for fast-track protocol failure.
Hence, despite the inherent limitations of a retrospective
study, we have identified one procedural (fluoroscopy
time ≥12 min) and three preoperative clinical variables
to be associated with fast-track protocol failure. Pre-
operative clinical variables included, age ≥85 years, poor
left ventricular ejection fraction (LV-EF ≤30 %) and
moderate to severe preoperative mitral valve regurgita-
tion. Recently, D’Onofrio and co-workers reported on
the impact of preoperative mitral valve regurgitation
on outcomes in 176 consecutive patients undergoing
TA-TAVI in a single-centre prospective study setting.
They showed that patients with a mitral valve regur-
gitation ≥2+ had higher surgical risk and a trend to-
wards higher in-hospital mortality [28].
While initial TA-TAVI cases in our series were per-
formed using the first generation of the balloon expand-
able system significant and relentless technological
advances have resulted in new and improved delivery
systems and valves. On the other hand at the beginning
of the TAVI era, only highest risk patients who were no
suitable candidates for open surgery were considered for
TAVI. With gaining experience in trancatheter ap-
proaches and increased procedural acceptance not only
non-surgical-candidates but also high-risk candidates
were included in our TAVI-program. Nevertheless a
comparison of demographic data and outcomes of the
early vs. late TA-TAVI treated patients could not reach a
statistical significance in Group F in our series.
Conclusions
In conclusion, fast-track patient management following
TA-TAVI is safe and successful in the majority of pa-
tients. Besides patient-related preoperative risk factors
(age ≥85 years, EF ≤30 % and severe preoperative mitral
valve regurgitation), a technically challenging intraopera-
tive course, as evidenced in prolonged fluoroscopy time,
are independent predictors of fast-track management
failure, which, in turn, is associated with prolonged hos-
pital stay and dramatic worsening of patient outcome.
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